Therapeutic compounds

Details for Australian Patent Application No. 2008286823 (hide)

Owner Allergan, Inc.

Inventors Gil, Daniel W.; Bhat, Smita S.; Corpuz, Evelyn G.; Heidelbaugh, Todd M.; Fang, Wenkui K.; Sinha, Santosh C.; Chow, Ken; Gomez, Dario G.

Agent Davies Collison Cave

Pub. Number AU-A-2008286823

PCT Pub. Number WO2009/023757

Priority 60/955,964 15.08.07 US

Filing date 14 August 2008

Wipo publication date 19 February 2009

International Classifications

C07D 233/50 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

A61K 31/4168 (2006.01)

A61K 31/421 (2006.01) - 1,3-Oxazoles, e.g. pemoline, trimethadione

A61K 31/426 (2006.01) - 1,3-Thiazoles

A61P 25/04 (2006.01) Drugs for disorders of the nervous system

C07D 263/28 (2006.01) Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings

C07D 277/18 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

Event Publications

11 March 2010 PCT application entered the National Phase

  PCT publication WO2009/023757 Priority application(s): WO2009/023757

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008286824-Heterocyclyl substituted fused carbocyles useful in the treatment of conditions such as glaucoma and pain

2008286818-Adrenergic compounds